The Role of Combination Therapy in mCRPC

Rashid K. Sayyid, MD, MSc, discusses the role of combination therapy in metastatic castrate-resistant prostate cancer.

Related Keywords

,Prostate Cancer Treatment Landscape ,Combination Therapy ,Prostate Cancer ,Prostate Cancer Treatments ,Parp Inhibitors ,Metastatic Castrate Resistant Prostate Cancer ,Nmcrpc ,Talazoparib ,Enzalutamide ,Olaparib ,Abiraterone ,Brca ,Radium 223 ,